Daiichi Sankyo announced that the first patient has been dosed in the global phase 3 TROPION-Lung17 trial. The study is evaluating DATROWAY in patients with locally advanced or metastatic nonsquamous ...
Forbes contributors publish independent expert analyses and insights. Podcast and video host & producer, journalist and speaker/moderator. Every year, thousands of life-saving clinical trials are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results